Clinical trials sponsored by Multitude Therapeutics Inc.

Phase breakdown

Conditions studied

Recruiting trials led by Multitude Therapeutics Inc.

• A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer
  NCT07474727 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 19 locations
• AMT-116 in Combination With AK112 in Patients With Lung Cancer
  NCT07590531 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• AMT-253 in Patients With Advanced Solid Tumours
  NCT06209580 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials is Multitude Therapeutics Inc. recruiting for?

Multitude Therapeutics Inc. is the lead sponsor of 3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.